-----------------------DOSAGE AND ADMINISTRATION---------------------- 15 mg given once weekly as an intramuscular injection for 12 weeks (2).  AMEVIVE should not be initiated if CD4+ lymphocytes are below normal. Monitor CD4+ T lymphocyte counts every two weeks during the dosing period. If CD4+ T lymphocyte counts are below 250 cells/μL, withhold dosing and institute weekly monitoring. Disco...

BACKGROUND CD4 lymphocyte counts are used to monitor immune status in HIV disease. An understanding of the variability of CD4 counts which occurs in the absence of HIV infection is essential to their interpretation. The sources and degree of such variability have not been extensively studied. OBJECTIVES To establish reference ranges for CD4 counts in HIV-seronegative women and heterosexual me...

OBJECTIVE To assess toxicities associated with highly active antiretroviral therapy (HAART) among HIV-1-infected pregnant women treated with nevirapine-based regimens according to Mozambican national guidelines. STUDY DESIGN Prospective cohort study. METHODS HIV-1-infected antiretroviral-naive pregnant women with CD4 counts < or =350 cells/microL were initiated on nevirapine, lamivudine, an...

Background and Objective: Opportunistic infections are the leading cause of death among patients subjected to the human immunodeficiency virus (HIV) infection and acquired immune deficiency syndrome (AIDS). The aim of this study was to compare the seroprevalence of Cytomegalovirus (CMV)  and toxoplasmosis infection in newly diagnosed HIV infected patients with healthy controls and it’s correlat...

PURPOSE Patients with high-grade gliomas (HGG) routinely receive radiation, temozolomide, and glucocorticoids. As each of these is immunosuppressive, we conducted a prospective, multicenter study to follow CD4 counts over time and determine whether low CD4 counts were associated with adverse outcomes. EXPERIMENTAL DESIGN Patients with newly diagnosed HGG had CD4 counts drawn before initiating...

BACKGROUND Patients accessing antiretroviral treatment (ART) programmes in sub-Saharan Africa frequently have very advanced immunodeficiency. Previous data suggest that such patients may have diminished capacity for CD4 cell count recovery. METHODS Rates of CD4 cell increase were determined over 48 weeks among ART-naïve individuals (n = 596) commencing ART in a South African community-based A...

INTRODUCTION The clinical value of monitoring CD4 counts in immune reconstituted, virologically suppressed HIV-infected patients is limited. We investigated if absolute lymphocyte counts (ALC) from an automated blood counting machine could accurately estimate CD4 counts. MATERIALS AND METHODS CD4 counts, ALC and HIV viral load (VL) were extracted from an electronic laboratory database for all...

Use of the standard dual-platform flow cytometric method for determination of CD4(+) T-lymphocyte counts, which needs both a flow cytometer (FCM) and hematological analyzer, would inevitably lead to increased variability. The development of new single-platform (SP) FCMs that provide direct CD4(+) T-lymphocyte counts for improved assay precision and accuracy have recently attracted attention. Th...

BACKGROUND The rate and extent of CD4 cell recovery varies widely among HIV-infected patients with different baseline CD4 cell count strata. The objective of the study was to assess trends in CD4 cell counts in HIV-infected patients after initiation of antiretroviral therapy in Tigray, Northern Ethiopia. METHODS A retrospective cross-sectional study was conducted by reviewing medical records ...